Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients

doi:10.3748/wjg.v18.i29.3910

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3708)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

383

HTML

2800

Figures (1-2)

285

Tables (1-4)

240

Sum=3708

Aug 7, 2012 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 7, 2012; 18(29): 3910-3916
Published online Aug 7, 2012. doi: 10.3748/wjg.v18.i29.3910

Full Size Figure Download Figure

Figure 1 The treatment subgroups of the cohort of 228 patients in this retrospective study. CEA: Carcinoembryonic antigen; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease.

Citation: Chen S, Chen YB, Li YF, Feng XY, Zhou ZW, Yuan XH, Qian CN. Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients. World J Gastroenterol 2012; 18(29): 3910-3916
URL: https://www.wjgnet.com/1007-9327/full/v18/i29/3910.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i29.3910